Stay updated on Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows a glossary and updates metadata labels related to quality control and versioning (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), while the previous labels (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4) were removed.SummaryDifference0.2%

- Check15 days agoChange DetectedThe page revision note was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedA consolidated 'Locations' section now lists study sites in Florida, Illinois, Massachusetts, and New York, replacing the previous separate 'Florida Locations', 'Illinois Locations', 'Massachusetts Locations', and 'New York Locations' subsections. The footer link to HHS Vulnerability Disclosure has been removed.SummaryDifference0.5%

- Check65 days agoChange DetectedThe page displays Revision: v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

- Check72 days agoChange DetectedPublications note updated to indicate PubMed entries are auto-filled and may not relate to the study, and Revision: v3.3.1 added; older wording and Revision: v3.2.0 were removed.SummaryDifference0.1%

- Check80 days agoChange DetectedThe site-wide funding-status notice about potential delays and operating status has been removed. The message previously directed users to the NIH Clinical Center and OPM for status updates.SummaryDifference0.4%

Stay in the know with updates to Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.